What is Sematrinity 4 mg Pre-filled Pen

Sematrinity 4 mg Pre-filled Pen contains the FDA-approved Semaglutide base and is used once weekly to support chronic weight management and improve blood sugar control in adults, along with exercise and diet. Semaglutide belongs to the Glucagon-like Peptide-1 (GLP-1) receptor agonist class. Sun Pharmaceutical Industries Ltd. produces this medicine under GMP-compliant manufacturing standards.

Semaglutide works by copying the action of the natural GLP-1 hormone. It increases insulin release when blood sugar is high, lowers glucagon secretion, slows stomach emptying, and reduces appetite. These effects help improve glycaemic control and support weight loss in adults with obesity or excessive weight associated with weight-related health conditions.

Inject Sematrinity under the skin of the abdomen, thigh, or upper arm once a week on the same day each week. Do not self-administer unless specifically trained or directed by the doctor. If a dose is missed and fewer than 5 days have passed, take it as soon as remembered. If more than 5 days have passed, skip it and return to the regular schedule. Never double the dose. In an overdose, severe nausea, vomiting, diarrhea, or low blood sugar can occur, so urgent medical help is needed.

Common side effects of the medicine are nausea, vomiting, dizziness, and injection-site reactions. Seek medical help immediately for severe abdominal pain, signs of pancreatitis, allergic swelling, breathing trouble, jaundice, fainting, or sudden vision changes.

Use caution in people with Pancreatitis, Diabetic Retinopathy, severe stomach problems, or a personal or family history of Medullary Thyroid Carcinoma or MEN 2. It can interact with insulin, sulfonylureas, and some oral medicines due to delayed gastric emptying.

Store unopened pens in a refrigerator at 2°C to 8°C, protect from light, and never freeze.

What are the benefits of taking Sematrinity 4 mg Pre-filled Pen

Sematrinity 4 mg Pre-filled Pen supports weight loss and better blood sugar control when used with a healthy diet and regular exercise. Key benefits are:

• It helps reduce body weight by lowering appetite, controlling food cravings, and prolonging the feeling of fullness after meals.
• It improves blood sugar control by improving insulin release when needed and lowering excess glucagon levels.
• It supports better metabolic health by helping reduce waist size and improving weight-related health risks over time.
• It can help lower cardiovascular risk in adults with Obesity or Type 2 Diabetes by supporting healthier long-term weight and glucose control.

How to take Sematrinity 4 mg Pre-filled Pen

Sematrinity Pre-filled Pen is a prescription injection and should be used exactly as directed by a doctor. The following are general instructions for proper use.

• Inject it once a week on the same day, or as prescribed by your doctor. Do not self-administer unless trained by a doctor or a nurse.
• It is typically given into the abdomen, thigh, or upper arm, and the injection site is rotated each week.
• It can be taken with or without food.
• Follow the prescribed schedule regularly for best results.

Strengths and Substitutes

As of now, only 1 strength of Sematrinity 4 mg Pre-filled Pen is available at Cheap Medicine Shop. However, you can find effective substitutes with the same active ingredient to suit your medical requirements. Always consult a doctor before opting for them.

View all substitutes

What are the side effects of Sematrinity 4 mg Pre-filled Pen

Sematrinity is generally well tolerated, but mild side effects may occur as the body adjusts to the medicine. These effects often improve with time. Common Sematrinity 4 mg pen side effects are:

• Nausea
• Vomiting
• Diarrhea
• Stomach pain
• Indigestion
• Headache
• Injection-site reactions

However, if they continue, worsen, or feel severe, consult a doctor immediately.

Safety Advice

Liver Disease

There is limited data on the use of Sematrinity 4 mg Pre-filled Pen in patients with liver disease. It should be used only if clearly needed and under regular medical supervision.

Kidney Impairment

There is limited data on Sematrinity 4 mg in people with kidney disease, so careful use is advised. Dose adjustment and close follow-up may be needed, especially in moderate to severe chronic kidney disease.

Pregnant and Breastfeeding women

The safety of Sematrinity 4 mg during pregnancy has not been fully established. It should be used only if the expected benefit clearly outweighs the possible risk and no safer option is available. Breastfeeding data is limited, so semaglutide is generally not recommended unless a specialist advises it after weighing the risks and benefits.

Avoid

Avoid this medicine if there is a known hypersensitivity or allergy to Semaglutide. Avoid alcohol as it can worsen nausea, vomiting, dehydration, and low blood sugar risk while using Sematrinity 4 mg, especially with Insulin or Sulfonylureas. Avoid driving or operating machinery if weakness, shakiness, confusion, or lightheadedness occurs.